(Q71995622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

The inhibitory effect caused by suramin on the paracrine growth of human cancer cells and fibroblasts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

H Mukaida

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

N Hirabayashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Hirai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Y Yamashita

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Iwata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

S Saeki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Toge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

234-240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

Secretion of transforming growth factor-beta by human myelogenous leukemic cells and its possible role in proliferation of the leukemic cells

22 October 2019

cites work

1 reference

12 December 2020

Suramin binds to platelet-derived growth factor and inhibits its biological activity

1 reference

12 December 2020

Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4

1 reference

12 December 2020

Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A

1 reference

12 December 2020

Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: secretion of a polypeptide which stimulates reductive 17 beta-oestradiol dehydrogenase activity

1 reference

12 December 2020

Enhancement of growth of human colon tumor cell lines by feeder layers of murine fibroblasts

1 reference

12 December 2020

Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide

1 reference

12 December 2020

Suramin: With Special Reference to Onchocerciasis

1 reference

12 December 2020

Growth of normal and neoplastic mouse mammary epithelial cells in primary culture: stimulation by conditioned medium from mouse mammary fibroblasts

1 reference

12 December 2020

Suramin inhibits proliferation of rat glioma cells and alters N-CAM cell surface expression.

1 reference

12 December 2020

Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease

1 reference

12 December 2020

Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases.

1 reference

12 December 2020

Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin

1 reference

12 December 2020

Suramin: an anticancer drug with a unique mechanism of action.

1 reference

12 December 2020

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

1 reference

12 December 2020

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

1 reference

12 December 2020

Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.

1 reference

12 December 2020

Inhibition of human immunodeficiency virus type I reverse transcriptase by suramin-related compounds

1 reference

12 December 2020

Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02032894

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003867%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference